Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation  by Strutz, Frank et al.
Kidney International, Vol. 61 (2002), pp. 1714–1728
Role of basic fibroblast growth factor-2 in
epithelial-mesenchymal transformation
FRANK STRUTZ,1 MICHAEL ZEISBERG,1 FUAD N. ZIYADEH, CHANG-QING YANG,
RAGHU KALLURI, GERHARD A. MU¨LLER, and ERIC G. NEILSON, with the technical
assistance of A. RENZIEHAUSEN and Z. SISIC
Department of Nephrology and Rheumatology, Georg-August University Medical Center, Go¨ttingen, Germany; Penn Center for
Molecular Studies of Kidney Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, Program in Matrix Biology,
Divisions of Nephrology and Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston,
and Department of Medicine and Cell Biology, Vanderbilt University, Nashville, Tennessee, USA
plus FGF-2. Conversely, the mesenchymal markers -smoothRole of basic fibroblast growth factor-2 in epithelial-mesenchy-
muscle actin (SMA) and FSP1 were induced with FGF-2 bymal transformation.
2.2  0.1-fold and 6.8  0.9-fold, respectively. Interestingly,Background. Epithelial-mesenchymal transformation (EMT)
plays an important role in embryonic development and tumori- de novo expression of the mesenchymal marker OB-cadherin
genesis and has been described in organ remodeling during was induced only by FGF-2 and EGF but not by TGF-1. All
fibrogenesis. In the kidney, EMT can be induced efficiently in three cytokines stimulated FSP1 and decreased E-cadherin
cultured proximal tubular epithelium by coincubation of trans- promoter activity. FGF-2 also induced intracellular fibronectin
forming growth factor (TGF)-1 and epidermal growth factor synthesis but not secretion, the latter of which was stimulated
(EGF). Recently, we also have observed overexpression of basic exclusively by TGF-1. Finally, zymographic analyses demon-
fibroblast growth factor-2 (FGF-2) protein and mRNA in hu- strated that FGF-2 induced MMP-2 activity by 2.6  0.5-fold
man kidneys with marked interstitial fibrosis. The aims of the and MMP-9 activity by 2.4  0.1-fold, providing a mechanism
present study were to compare the effects of FGF-2 as a facilita- for basement membrane disintegration and migratory access
tor of EMT in tubular epithelial cells with EGF and TGF-1. of transforming epithelium to the interstitium.
We analyzed the morphogenic effects of the three cytokines on Conclusions. FGF-2 makes an important contribution to the
four different aspects of EMT: cell motility, expression and mechanisms of EMT by stimulating microenvironmental prote-regulation of cellular markers, synthesis and secretion of extra-
ases essential for disaggregation of organ-based epithelial units.cellular matrix (ECM) proteins as well as matrix degradation.
Furthermore, the expression of epithelial and mesenchymalMethods. Cell motility was studied by a migration assay and
marker proteins seems to be affected at the promoter level.cell differentiation markers were analyzed by immunofluores-
cence and immunoblots. In addition, regulation of the epithelial
adhesion molecule E-cadherin and fibroblast-specific protein
1 (FSP1) were analyzed by luciferase reporter constructs and Interstitial fibrosis and tubular atrophy are structuralstable transfections. ELISAs for collagen types I and IV and
markers of end-stage renal failure. The degree of tubulo-fibronectin were used for ECM synthesis, and zymograms were
utilized for analysis of matrix degradation. interstitial scarring is an excellent prognostic marker for
Results. FGF-2 induced cell motility across a tubular base- progressive organ failure [1]. Fibroblasts are thought to
ment membrane in two tubular cell lines. All three cytokines be the main effector cells in renal fibrogenesis. These cellsinduced the expression of vimentin and FSP1, but only FGF-2
reside within the cortical interstitial spaces of the kidneyand TGF-1 reduced cytokeratin expression by immunofluo-
rescence. These effects were most demonstrable in the distal or in perivascular areas. When fibroblasts activate, some
tubular epithelial cell line and were confirmed by immunoblot phenotypically convert to myofibroblasts that are marked
analyses. Expression of E-cadherin was reduced by 61.5  by the de novo expression of -smooth muscle actin3.3% and expression of cytokeratin by 91  0.5% by TGF-1
(SMA) [2]. Not all collagen-producing fibroblasts make
this conversion, and it has been speculated that some of
1 Dr. Strutz and Dr. Zeisberg contributed equally to this work. the scattered SMA cells in the interstitium may be vas-
cular smooth muscle cells [3]. FSP1 cells proliferate andKey words: kidney fibrosis, extracellular matrix, EGF, EGFR, FGFR-1,
TGF-1. synthesize extracellular matrix products such as fibro-
nectin and collagen types I, III, IV and V. However, the
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they may be replenished, in part, from bone marrow the tubulointerstitial space that expressed mesenchymal
and epithelial markers simultaneously [15]. Recently,stromal cells [5] or tubular epithelial cells [6].
Tubular epithelial cells have several important func- Jinde et al described tubular phenotypic changes indicat-
ing EMT in human glomerulonephritis [16].tions in renal fibrogenesis. Initially, they react to protein-
uria by synthesizing chemoattractants such as endo- We have recently described the potential profibro-
genic role of FGF-2 in human renal fibrogenesis [17, 18].thelin-1 (ET-1), RANTES (regulated upon activation,
normal T cell expressed and secreted), and monocyte The aim of the present study was to analyze the effects
of FGF-2 on EMT in tubular epithelial cells in vitro andchemoattractant protein-1 (MCP-1) [7]. All three moie-
ties are strong attractants for monocytes/macrophages compare these effects with the effects induced by EGF
and TGF-1. Four different aspects of EMT were ana-that help to form early tubulointerstitial infiltrates. These
interstitial infiltrates are thought to release profibroge- lyzed: cell motility, expression and regulation of epithe-
lial and mesenchymal markers, synthesis of ECM pro-nic morphokines such as transforming growth factor-
(TGF-) and platelet-derived growth factor (PDGF), teins, and degradation of basal membrane.
which in turn activate and cause fibroblasts to divide. At
another level, tubular epithelial cells may stimulate the
METHODS
activation of fibroblasts directly by their secretion of
MaterialsTGF-1 and PDGF. Finally, tubular epithelium may con-
tribute to the formation of extracellular matrix. Creely Human recombinant EGF, FGF-2 and TGF-1 were
purchased from R&D Systems (Minneapolis, MN, USA),and coworkers demonstrated that TGF- induced colla-
gen type I production in rat tubular epithelial cells [8]. as were the neutralizing antibodies to EGF (goat poly-
clonal), FGF-2 (goat polyclonal), and TGF- (chickenSimilarly, TGF-1 stimulated fibronectin and proteogly-
can synthesis in rabbit proximal tubule cells [9]. Collagen polyclonal). Antibodies to EGF (rabbit polyclonal) and
FGF-2 (mouse monoclonal) and to receptors for EGFtype I synthesis in tubular epithelial cells also is stimu-
lated by hyperglycemia [10]. We have cloned a murine (EGFR) (rabbit polyclonal) and FGF-2 (FGFR-1) (rab-
bit polyclonal) were from Calbiochem-Novabiochem (Sanfibroblast-specific protein FSP1 [11]; FSP1 is a 11.5-kD
cytoskeletal protein belonging to the calmodulin-S100- Diego, CA, USA) and Santa Cruz Biotechnology (Santa
Cruz, CA, USA), respectively. The following antibodiestroponin C superfamily of intracellular calcium binding
proteins that are involved in cell motility and mesenchy- were used for cell characterization, immunocytochemis-
try and immunoblot studies: anti-cytokeratin (mousemal phenotype [12]. In mouse models of antiglomerular
and antitubular basement membrane disease, selected monoclonal which reacts with keratins 5, 6, 8, and 17;
Dako, Carpinteria, CA, USA), anti-E-cadherin (rat mono-tubular cells express FSP1 de novo. We interpret this find-
ing as a sign of potential epithelial-mesenchymal trans- clonal; Takara, Shiga, Japan), anti-ZO-1 (rat polyclonal;
Chemicon, Temecula, CA, USA), anti-vimentin (mouseformation (EMT).
The process of EMT is characterized by a loss of api- monoclonal; Boehringer Mannheim, Mannheim, Ger-
many), anti-SMA (mouse monoclonal; Paesel  Lorei,cal-basal polarity, cellular adhesion molecules, and cell-
cell junctions of involved epithelium [13]. Epithelium in Wiesbaden, Germany), and OB-cadherin (goat poly-
clonal; Santa Cruz). Synthesis and characterization oftransition develop front and back-end polarity and be-
come mobile. The intermediate filament profile changes the anti-FSP1 antibody have been described before [11].
For the enzyme-linked immunosorbent assay (ELISA)from cytokeratin to vimentin, the F-actin fibers reform
to a mesenchymal format, and some begin to become technique, antibodies to collagen type I (rabbit poly-
clonal; Biodesign, Kennebunk, ME, USA), collagen typeSMA. Moreover, the cells reverse the types of extracel-
lular matrix they synthesize from basement membrane IV (rabbit polyclonal; Biodesign) and fibronectin (rab-
bit polyclonal; Sigma) were used. Trypsin-EDTA (0.05/type to interstitial matrix components [14]. Okada et al
were able to demonstrate that FSP1 expression can be 0.02%, wt/vol), Dulbecco’s modified Eagle’s medium
(DMEM), Iscove’s modified Dulbecco’s medium and fe-induced most effectively by a combination of EGF and
TGF-1 [2]. Furthermore, this group demonstrated an tal calf serum (FCS) were obtained from Gibco BRL
Ltd. (Paisley, Scotland, UK). Cell culture dishes wereearly role of FSP1 in EMT since antisense oligonucleo-
tides for FSP1 inhibited EMT at an early stage. Ng and from Becton Dickinson (Franklin Lakes, NJ, USA).
coworkers demonstrated that rat tubular epithelial cells
Cell cultureacquire SMA expression in a model of interstitial fibrosis
and fulfill the criteria of a mesenchymal cell by electron The tubular epithelial cell line NP-1 was generated
from freshly isolated tubuli from a C57BL/6J mouse.microscopy [6]. The change of cell phenotype was accom-
panied by disruption of the basal membrane. Similarly, Cortical slices were dissected and dissociated by treat-
ment with collagenase. Tubule fragments were washedNadasdy and coworkers analyzed human end-stage kid-
neys and found single cells or small cell clusters within and resuspended in defined medium (DMEM:Ham’s F12;
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1:1 vol/vol) containing insulin (0.5 g/mL), triiodothy- Assessment of cell motility
ronin (1 mol/L), transferrin (5 g/mL), EGF (10 ng/ Cell motility was assessed by migration assay. In order
mL), dexamethasone (50 nmol/L) and 5% FCS. Cell to mimic the microenvironment of tubular basement
characterization was done by immunocytochemistry. membrane and renal interstitium, polyvinyl-pyrolidone-
Cells were seeded in microchamber slides and incubated free (PVPF) polycarbonate membranes with 8 m pores
for 12 hours. They were subsequently fixed with ethanol/ (Neuro Probes, Inc., Gaithersburg, MD, USA) were
acetic acid (50:50, vol/vol) for 20 minutes at 4C, washed coated with type IV collagen on the upper side (50 g/
and incubated with the primary antibody for two hours mL) and with type I collagen on the lower side (50 g/
at room temperature. Cells were then washed again with mL). The lower wells of a 48-well Boyden chamber were
phosphate-buffered saline (PBS) and incubated for 60 filled with DMEM medium alone. Wells were covered
minutes at room temperature with the appropriate FITC- with the coated membrane sheet and 2  104 cells/well
conjugated secondary antibody. Control cultures were were added into the upper chamber either in DMEM
incubated without application of the primary antibody. alone or with FGF-2 in concentrations of 0.1, 1.0, and
Cell characterization was performed using the following 10 ng/mL. EGF and TGF-1 (5 ng/mL each) was used
antibodies: anti-cytokeratin, anti-E-cadherin, anti-ZO-1, as a positive control. The Boyden chamber was incubated
for four hours at 37C to allow possible migration ofanti-vimentin, anti-SMA, and anti-FSP1. All cells were
cells through the membrane into the lower chamber.positive for cytokeratin, ZO-1, and E-cadherin, and were
Membranes were stained with Hema3 stain accordingnegative for vimentin, FSP1 and SMA. In addition, seg-
to manufacturer’s recommendations (Biochemical Sci-ment-specific lectin binding using Dolichus biflorus ag-
ences, Inc., Swedesboro, NJ, USA). Cells that migratedglutinin (DBA) as a marker for distal and collecting
through the membrane were counted using a countingtubules revealed positivity in all cells, whereas it was
grid, which was fitted into the eyepiece of the phasenegative for the proximal tubule marker Lotus tetraglo-
contrast microscope. All experiments were repeatednolobus (LTA). Furthermore, NP-1 cells did not stain
three times.positively for alkaline phosphatase (data not shown).
These data indicate that NP-1 cells represent a cell type
Expression of epithelial and mesenchymal markersof the distal tubule.
The expression of epithelial and mesenchymal mark-Mouse proximal epithelial tubule (MCT) cells, NIH/
ers was analyzed by indirect immunofluorescent labeling3T3 fibroblasts and the mouse kidney fibroblast line TFB,
and immunoblot analyses. For indirect immunofluores-which have been characterized previously [19, 20], were
cence labeling, NP1 and MCT tubular epithelial cellscultured in DMEM supplemented with 10% FCS, peni-
were plated at a density of 5  106/mL on 10-wellcillin (100 U/mL) and streptomycin (100 U/mL).
multitest slides (ICN, Costa Mesa, CA, USA) and serum-
deprived for 24 hours. Subsequently, cytokines wereImmunoblot analyses for EGFR and FGFR-1
added at a concentration of 1 ng/mL. After 72 hoursImmunoblots for expression of EGFR and FGFR-1
immunocytochemistry was performed as described abovewere performed as described before [17]. Briefly, lysates
using indirect immunofluorescence to stain for the epi-from MCT and NP-1 tubular epithelial cells were ob-
thelial markers cytokeratin and for the mesenchymaltained by lysis with a detergent-based buffer containing
markers vimentin and FSP1. Anti-cytokeratin antibody
0.4% sodium deoxycholate, 1% NP-40, 1.9% EGTA and
was used at 1:20, anti-vimentin at 1:10, and anti-SMA
10 mmol/L Tris (pH 7.4). 100 g of total cellular protein at 1:50. The secondary FITC-labeled antibodies (anti-
were run on 12.5% sodium dodecyl sulfate-polyacryl- mouse or anti-rat; both from Dako) were used at 1:50.
amide gel electrophoresis (SDS-PAGE) gel and trans- In a second series of experiments, cell density was de-
ferred to a nitrocellulose membrane (Hybond ECL; creased to 1  106/mL and cells were incubated with 1
Amersham, Braunschweig, Germany) by electroblotting. ng/mL FGF-2 for 72 hours. Additional staining with the
Membranes were stained with Ponceau red to control Hoechst dye H33258 to identify nuclei was performed
for adequate transfer and equal loading. After blocking, to facilitate cell counting in that experiment. For each
the membrane was incubated with the respective anti- group, 500 cells were determined microscopically using
body [anti-EGF and anti-FGF-2 at a concentration of an Axiophot S100 microscope (Zeiss, Jena, Germany)
1:100, anti-EGFR at 1:80, and anti-FGFR-1 (flg) in a con- by a blinded investigator and the percentage of positive
centration of 1:40] followed by the secondary antibody cells was calculated. Each experiment was repeated three
[anti-goat (Santa Cruz) or anti-rabbit (Amersham) horse- times independently. Again, neutralizing antibodies to
radish-peroxidase-linked, at concentrations of 1:12,000 the respective cytokines were added in the concentra-
and 1:3000, respectively]. Positive reaction products were tions as above to control for specificity. In addition, the
identified by chemiluminescence (ECL; Amersham) ac- effect of an irrelevant IgG (anti-HLA-DR) was exam-
ined in a concentration of 10 g/mL.cording to the manufacturer’s protocol.
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Further quantification of expression of epithelial and (pUvo214luc), 107 (pUvo107luc) and 17 (pUvo17luc) bp
upstream of the transcriptional start site. All constructsmesenchymal markers was obtained by immunoblot
analyses for the epithelial markers E-cadherin and cyto- were confirmed by sequence analysis. These deletion
fragments were transiently transfected into MCT, NP1keratin and the mesenchymal markers SMA, FSP1 and
OB-cadherin in NP1-cells. Cells were cultured in flasks and NIH/3T3 cells using co-transfections with pCH110
(Pharmacia, LKB Biotechnology, Piscataway, NJ, USA),until reaching confluence and were then stimulated with
the appropriate cytokine or cytokine combination in a a vector expressing -galactosidase, for normalization as
described [11]. pSV2luc containing the SV40-promoter/total concentration of 1 ng/mL. Furthermore, in order
to study dose dependency, FGF-2 was added to confluent enhancer served as a positive control. Since pUvo214luc
displayed by far the strongest activity in both tubularcell cultures at concentrations of 0.1, 1.0 and 10.0 ng/mL
for 72 hours. Total cellular protein was harvested after epithelial cell lines (49.1  4.3% of pSV2luc in NP1 and
42.4  3.4% in MCT compared to 9.1  1.4% in NIH/24, 48, 72, or 96 hours of incubation using the detergent-
based buffer described above. One hundred nanograms 3T3 fibroblasts), this construct was stably transfected
into NP1 cells as described above. Stable transfectantsof protein were run on 18 or 15% SDS-PAGE gel and
blotted overnight. Primary antibodies were used in the were stimulated by FGF-2, EGF, and TGF-1, or combi-
nations of TGF-1 and EGF or FGF-2 at a total concen-following concentrations: anti-E-cadherin 1:100, anti-
cytokeratin 1:100, anti-SMA 1:100, anti-FSP1 1:15,000, tration of 1 ng/mL for 48 hours before measurement.
All luciferase activities were measured by cell lysis inand anti-OB-cadherin 1:200. The secondary horseradish
peroxidase-linked antibodies were used at the following KPO4-DTT with 1% Triton X-100 and assays of the
supernatants in a luminometer (Mikrolumat CB 96P;concentrations: anti-goat 1:12,000, anti-rabbit 1:3000,
anti-mouse 1:1500, and anti-rat 1:1000 (the latter two Berthold, Bad Wildbad, Germany). Light units of stable
transfectants were normalized for cell number. Stimula-from Amersham). Positive reaction products were again
identified by chemiluminescence using a Fluor-SMulti- tions were repeated five times independently and results
are given as relative percentage compared to unstimu-imager (Bio-Rad, Hercules, CA, USA) and densitomet-
ric analysis was performed using Multi-Analyst soft- lated stable transfectants.
ware (Bio-Rad). Values of densitometric analyses were
Analysis of extracellular matrix synthesiscorrected for protein loading. All experiments were re-
peated three times with independent stimulations. Extracellular matrix (ECM) synthesis was evaluated
by ELISAs for collagen types I and IV and for fibronectin
Stable transfections with FSP1 and E-cadherin in both cell lines. In addition, immunoblot analyses for
luciferase minigenes intracellular fibronectin synthesis were performed in
NP1-cells. ELISAs of supernatants were performed asFor further analyses of FSP1 and E-cadherin regula-
tion, stable transfections in NP1 cells were performed. described previously [17]. Briefly, 8 103 cells were plated
per well and cells were made quiescent by incubation inThe characterization of the FSP1 promoter has been
described in detail before [21]. The luciferase reporter serum-free medium for 24 hours. Next, cytokines were
added in a concentration of 1 ng/mL followed by incuba-construct pBK1800luc containing an 1800 bp fragment
of the 5 flanking region of the FSP1 gene was transfected tion for 72 hours. Both 50 g/mL ascorbic acid and 50
g/mL propionitrile (both from Sigma) were added ininto NP1 cells using CaPO4 as described elsewhere [11].
Cotransfections with pMCNeobGal (Stratagene) in a experiments evaluating collagen synthesis. Supernatants
were transferred to a Maxisorp plate (Nunc) and incu-molar ratio of 10:1 favoring pBK1800luc were used for se-
lection. In pBK1800luc, the luciferase gene is placed under bated overnight at room temperature. Plates were subse-
quently dried for two hours and blocked with 3% milk.the control of the FSP1 promoter. This construct demon-
strated activity exclusively in fibroblasts [11]. Twenty- Incubation with 50 L of the primary antibody (anti-
collagen type I at a concentration of 1:200, anti-collagenfour hours after transfection, cells were subjected to se-
lective medium (DMEM  400 g/mL Genetecin) for type IV at 1:10,000, and anti-fibronectin at 1:5000) was
followed by washing twice with PBS/0.1% Tween and14 days and then subcloned by limiting dilution. For
analysis of E-cadherin promoter activity, 3500 bp of the incubation with the secondary antibody (anti-mouse-
IgG-AP and anti-rabbit-IgG-AP (both Boehringer Mann-E-cadherin promoter (generous gift of Dr. J. Behrens,
Essen, Germany) was cloned into the pXP-2 luciferase heim), both used at a concentration of 1:1000). After
two additional wash steps 100 L chemiluminescence-vector placing the luciferase gene under control of the
E-cadherin promoter (pUvo3500luc) [22]. Since the ac- ELISA substrate (Boehringer Mannheim) was added and
quantitation was performed in a luminometer (Mikro-tivity of pUVO3500luc was not entirely specific for epi-
thelial cells as already described [22], a series of lucifer- lumat CB 96P; Berthold) using MikroWin software
(Mikrotek, Overath, Germany). Nonspecific binding wasase reporter minigenes were engineered by restriction
enzymes creating fragments of 495 (pUvo495 luc), 214 determined by incubation with the secondary antibody
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Fig. 1. Immunoblot analyses for epidermal
growth factor (EGF) receptor (A, 170 kD)
and basic fibroblast growth factor (FGF) re-
ceptor 1 (B, 120 kD) in MCT (mouse proximal
tubular epithelial cell line) and NP1 cells (dis-
tal tubular epithelial cell line). Both cell lines
express the two receptors.
only. The value was normally less than 5% of the total Matrix degradation
chemiluminescence and was subtracted from each assay. Effects of the three cytokines on gelatinase [matrix
All assays were performed in triplicates and repeated metalloproteinase-2 and -9 (MMP-2 and MMP-9)] were
five times. Standardization was obtained for the collagen analyzed by zymography in both tubular epithelial cell
type I ELISA using rat tail type I collagen (Sigma). Limit lines. Cells were plated at a density of 8  104/mL and
of detection was 1 ng/mL, working range 10 to 1000 ng/mL. growth-arrested in Iscoves medium for 24 hours. Cells
were subsequently stimulated with the appropriate cyto-Mouse collagen type IV isolated from basement mem-
kine at a concentration of 1 ng/mL for 72 hours. Cellbrane of Engelbreth-Holmes-Swarm mouse sarcoma
supernatants were 10 concentrated and equal amounts(Sigma) served as standardization for the type IV colla-
of total protein were loaded on SDS gel containing 1.0gen. Human fibronectin (Sigma) was used as standard
mg gelatin per mL, and electrophoresis on non-reducingfor the fibronectin ELISA; the working range of this
SDS-10% polyacrylamide gels (Biorad) was performed.ELISA was 0.1 to 10 g/mL with a limit of detection of
After 30 minutes of incubation in renaturation buffer10 ng/mL. All standards were purchased from Sigma.
containing 2.5% Triton X-100, gelatinolytic activity wasValues were corrected for cell counts that were per-
detected by an 18-hour incubation step in 5 mmol/Lformed after the transfer of supernatants and were ex-
CaCl2, 50 mmol/L Tris/HCl, pH 7.5 at 25C before Coo-pressed in ng or g/103 cells.
massie Brilliant Blue staining of the gels (0.5% Coomas-Immunoblot analyses of intracellular fibronectin were
sie blue in 40% methanol/10% acetic acid for 1 hour).performed as described above. Cells were stimulated
Destaining was performed in the same buffer devoid of
with the appropriate cytokine or cytokine combination
Coomassie blue for 15 minutes. The presence of the
at a concentration of 1 ng/mL for 24, 48, 72 and 96 hours. metalloproteinases was indicated by an unstained pro-
Furthermore, in order to study dose dependency, FGF-2 teolytic zone of the substrate. Molecular sizes of the
was added to confluent cell cultures at concentrations of bands displaying enzymatic activity were identified by
0.1, 1.0 and 10.0 ng/mL for 72 hours. The anti-fibronectin comparison to standard proteins and to purified MMPs
antibody was used in a concentration of 1:5000, the sec- (both from Calbiochem). Quantification was achieved by
ondary antibody at 1:3000. Human fibronectin served as densitometric analysis as described above.
positive control. Positive reaction products were identi-
Statistical analysisfied by chemiluminescence using a Fluor-S Multiimager
(Bio-Rad) and densitometric analysis was performed us- All values are expressed as mean  SEM. One-way
ing Multi-Analyst software (Bio-Rad). Values of densi- analysis of variance (ANOVA) was used to determine
statistical differences between growth factor treatedtometric analyses were corrected for protein loading.
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Fig. 2. Assessment of cell migration in NP1
tubular epithelial cells. Whereas in controls rel-
atively few cells were able to migrate through
the artificial basement membrane (A), stimu-
lation with FGF-2 resulted in a robust up-
regulation of migrated cells (B depicts stimu-
lation with 1.0 ng/mL and C 10 ng/mL). The
most robust stimulation was obtained with the
combination of EGF and TGF-1 (used in
this experiment at the concentrations of 5 ng/
mL for each cytokine). Magnification 100
and 400 (inlets). *P 	 0.05; **P 	 0.01.
groups and controls using Sigma-Stat-software 2.03 cytokine (Fig. 1). In addition, FGF-2 protein was detect-
able in MCT and NP1-cells by immunoblot analysis (not(Jandel Scientific, San Rafael, CA, USA). Bonferroni’s
method was applied to control for multiple testing. P shown), but not EGF protein. Thus, both cell lines ex-
values 	0.05 were considered significant. pressed the receptors for FGF-2 and EGF, though only
FGF-2 was synthesized by these cells.
RESULTS Induction of cell motility
Immunoblot analyses for EGFR and FGFR-1 Basic fibroblast growth factor-2 induced cell motility
as assessed by the migration assay in a dose dependentImmunoblot analyses demonstrated that the tubular
epithelial cell lines MCT and NP1 expressed type 1 re- fashion. Figure 2 illustrates the results obtained with
NP-1 cells. In addition to the promotion of migratoryceptors for FGF-2 and the EGF receptor making these
cells susceptible to the biologic effects of the respective capacity, cells developed a more fibroblastoid morphol-
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Fig. 3. Indirect immunofluorescence stain-
ings for the epithelial marker cytokeratin (A,
B, E and F ), and the mesenchymal marker
vimentin (C, D, G and H ) in NP1 tubular
epithelial cells. Cells were stimulated for 72
hours with EGF, FGF-2 or TGF-1 at a con-
centration of 1 ng/mL. Only results obtained
with FGF-2 are depicted. Panels A–D depict
the results obtained at high cell density, panels
E–H at low cell density. Stimulation with
FGF-2 (1 ng/mL) resulted in a down-regula-
tion of cytokeratin and an up-regulation of
vimentin protein expression. These changes
were more prominent at lower cell density.
Magnifications600 (A–D) and400 (E–H).
ogy (see inlets in Fig. 2 B–D vs. A of control). In MCT shown). The number of cytokeratin positive cells de-
creased from 98.7  2.0% to 38.5  3.5% (FGF-2) andcells, FGF-2 induced cell migration even more robustly
and dose dependently (163.5  16.2 cells at 0.1 ng/mL 31.6  5.1% (TGF-1), respectively, but was unchanged
after incubation with EGF alone (94.5  3.1%). Con-FGF-2, 181.7  20.6 at 1 ng/mL FGF-2, and 252  23.7
at 10 ng/mL FGF-2 vs. 39.5 10.3 of controls and 325.2 versely, all three cytokines resulted in increased expres-
sion of the two mesenchymal markers: Vimentin posi-21.3 for EGF  TGF, P for all 	0.01).
tivity increased to 74.5  5.2% after induction by EGF,
Differential effects on phenotypic cell markers to 79.3  4.3% after stimulation with FGF-2, and to
82.3  6.1% after addition of TGF-1 (controls wereExpression of phenotypic cell markers was first studied
by indirect immunofluorescence for the epithelial marker 25.4  4.1% positive). Similarly, FSP1 expression was
increased to 32.5  3.2%, 35.1  4.0, and 41.3  3.9%cytokeratin, as well as for the mesenchymal markers
vimentin and FSP1 in NP1 cells. Cytokeratin expression after stimulation with EGF, FGF-2 and TGF-1, respec-
tively (controls were only 12.4  3.5% positive). Addi-was down-regulated after 72 hours by FGF-2 and TGF-1
(Fig. 3), whereas EGF had no significant effect (not tion of neutralizing antibodies to the respective cytokine
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Fig. 5. FGF-2 results in dose dependent down-regulation of the epithe-
lial cell marker cytokeratin by Western blot analysis. NP-1 cells were
stimulated for 72 hours and cytokeratin expression was assessed by
immunoblot. Addition of 10 ng/mL FGF-2 resulted in the most robust
down-regulation whereas addition of a neutralizing antibody (nAb)
prevented the effect. Actin (43 kD) was used in this experiment to
control for equal protein loading (lower bands).
immunoblot analyses for the epithelial markers cytoker-
Fig. 4. Representative Western blot analyses and densitometric analy-
atin and E-cadherin, and for the mesenchymal markersses for E-cadherin expression in NP1 cells. Part A depicts a typical blot
obtained after stimulation for 96 h. Part B summarizes the results of FSP1, SMA and OB-cadherin were performed in NP1 cells
three blots after three independent stimulations after 0, 24, 48, 72, and (Figs. 4 to 8). Confirming the results of indirect immuno-
96 hours. Symbols are: controls (), and stimulations with EGF (),
fluorescence staining, cytokeratin expression was ro-FGF-2 ( ), TGF-1 ( ), TGF-1  EGF ( ), or TGF-1  FGF-2
( ). Whereas EGF and FGF-2 had only moderate effects on E-cadherin bustly decreased in a time-dependent fashion by TGF-1
expression, TGF-1 resulted in a significant reduction in expression and FGF-2, whereas EGF did have no decreasing effectafter 72 and 96 hours. These effects were potentiated by addition of
(not shown). FGF-2 had similar effects as TGF-1 (re-EGF or FGF-2. * P 	 0.05, ** P 	 0.01.
duction of cytokeratin expression by 62.1  2.2 and
68.3  5.2%, respectively). The dose dependency of
FGF-2 on cytokeratin expression is shown in Figure 4.
abolished its effects specifically, whereas the addition of Regarding E-cadherin expression, EGF and FGF-2 re-
a non-relevant IgG had no effect. Furthermore, the ef- duced its expression (maximal reduction by 18.0 7.2%
fects of FGF-2 on cytokeratin and vimentin expression after 96 h incubation with EGF) though only TGF-1
were studied at lower density since the cell density may decreased the expression significantly (maximal reduc-
have an effect on the expression of epithelial or mesen- tion by 35.3 4.2%; Fig. 5). The effects of TGF-1 were
chymal marker proteins. As shown in Figure 3 E–H, the potentiated by either EGF or FGF-2 (decrease of up to
cytokine reduced cytokeratin and increased vimentin ex- 61.5  3.3% after 96 h).
pression even more compared to high density experi- -Smooth muscle actin is a cytoskeletal protein that
ments (reduction of cytokine positive cells from 94.4  is expressed in vascular smooth muscle cells and (acti-
2.9 to 26.3  4.7 and increase of vimentin expressing cells vated) fibroblasts. Its expression was induced by FGF-2
from 5 1.7 to 83.3 4.6). Performing the same studies in and TGF-1 (Fig. 6). FGF-2 resulted in a robust increase
MCT cells resulted in qualitatively similar changes albeit in SMA beginning at 24 hours and reaching a peak at
somewhat less pronounced (data not shown). 48 hours (increase by 17.4-fold). Conversely, induction
by TGF-1 was not significant until 48 hours after addi-In order to further analyze these effects quantitatively,
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Fig. 7. Representative Western blots and summary of densitometricFig. 6. Immunoblot analyses for-smooth muscle actin (SMA) expres-
analyses for FSP1 in NP1-cells. Cells were stimulated for 0, 24, 48, 72,sion in NP1-cells. (A) Three typical blots for SMA (43 kD) after stimula-
and 96 hours. (A) Typical blots after stimulation with EGF (uppertion with EGF (upper panel), FGF-2 (middle panel) and TGF-1 (lower
panel), FGF-2 (middle panel) and TGF-1 (lower panel). (B) Re-panel). (B) Summary of the densitometric analyses of three indepen-
sults of densitometric analyses of three independent experiments. Con-dent stimulations with EGF (), FGF-2 ( ), TGF-1 ( ), TGF-1 
trols are shown in (). EGF () and TGF-1 ( ) had the most ro-EGF ( ) and TGF-1  FGF-2 ( ). Controls are depicted in ().
bust effects on FSP1 expression. Conversely, FGF-2 ( ) inducedEGF had no significant effect on -smooth muscle actin expression,
FSP1 less robustly. In addition, the last two columns display the ef-whereas FGF-2 and TGF-1 increased its expression up to 40-fold.
fects of TGF-1  EGF ( ) and TGF-1  FGF-2 ( ). * P 	 0.05,* P 	 0.05, ** P 	 0.01.
** P 	 0.01.
tion of the cytokine and peaked after 72 hours (increase
by 23.1-fold). The combination of TGF-1 and FGF-2 of non-classical cadherins that are expressed on cells
had similar effects as the single cytokines but had addi- with mesenchymal phenotype [23]. De novo synthesis of
tive effects after 96 hours (increase by 20.2-fold). EGF OB-cadherin was induced by EGF and FGF-2 in a time-
by itself, on the other hand, did not induce synthesis of dependent manner but not by TGF-1 (Fig. 8).
SMA, though in combination with TGF-1 its effects
Direct effects on promoter activitywere counterbalanced by the latter cytokine. However,
regarding FSP1 expression, EGF exerted more robust For further analysis of cytokine-mediated effects on
effects than FGF-2 and resulted in an increase of up to phenotypic markers, we next stably transfected lucifer-
8.0-fold after 72 hours (Fig. 7). TGF-1, again had the ase reporter constructs containing active 5-flanking re-
most pronounced effects after 96 hours (induction by 7.3- gions of the FSP1 and E-cadherin genes. The results are
fold). The combination of TGF-1EGF also increased summarized in Figure 9. E-cadherin promoter activity
FSP1 expression, but the combination of TGF-1 with was inhibited maximally by the combination of TGF-1
FGF-2 decreased the effects of TGF-1. Finally, we ana- and FGF-2 (24.5  2.1% of control). Conversely, FSP1
lyzed the effects of all three cytokines on the expression promoter was stimulated most robustly by EGFTGF-1
(216.8 5.9% compared to unstimulated control). Thus,of OB-cadherin (cadherin-11), a member of the family
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Fig. 8. Representative Western blot demon-
strating the effects of EGF, FGF-2, and TGF-1
on the expression of OB-cadherin in NP1 distal
tubular epithelial cells. De novo protein synthe-
sis for OB-cadherin is shown after incubation
with EGF (A), FGF-2 (B), and TGF-1 
FGF-2 (E ) starting at 24 hours after incubation.
Conversely, only minimal effects were observed
after incubation with TGF-1 (C ) and the com-
bination of TGF-1  EGF (D).
similarly to what was observed at the protein level, all The effects on fibronectin synthesis in NP1 were in
three cytokines reduced E-cadherin promoter activity addition examined by immunoblot analyses. These blots
and promoted FSP1 expression. There is a certain dis- demonstrated de novo expression of fibronectin protein
crepancy between the robust reduction of the E-cadherin induced by all three cytokines (Fig. 11). Thus, there is
promoter activity and the minor down-regulation of pro- a discrepancy between the induction of intracellular fi-
tein expression that could be explained by the long half bronectin synthesis by EGF and FGF-2 and the lack of
life of the molecule on the cellular surface [24]. effect of these two cytokines on fibronectin secretion. In
addition, the dose dependency of FGF-2 on fibronectinEffects of cytokines on extracellular matrix synthesis
protein synthesis was demonstrated (Fig. 11F). Con-
The effects of the three cytokines and the combina- versely, fibronectin synthesis and secretion were stimu-
tions of TGF-1 with EGF and FGF-2 on the secretion lated by TGF-1 and the cytokine combinations that
of collagen type I, collagen type IV and fibronectin are
included TGF-1, indicating that TGF-1 is possibly re-depicted in Figure 10. In MCT cells, collagen type IV
quired for secretion of this matrix protein.secretion was stimulated up to 29.7  3.3-fold and fibro-
nectin release was increased up to 9.0  0.6-fold by the Induction of matrix degradation
combination of FGF-2 and TGF-1. FGF-2 by itself had
All three cytokines induced type IV collagen degrad-only marginal effects as did EGF. There were no signifi-
ing enzymes MMP-2 and MMP-9 in both cell lines ascant effects of FGF-2 and EGF on secretion of type I
determined by gel zymography. In MCT cells MMP-2and type IV collagens in both cell lines. Conversely,
was induced up to 1.5  0.2-fold compared to controlcollagen type I secretion was induced up to 4.1  0.5-
(P not significant). MMP-9 was induced up to 1.6-foldfold and collagen type IV secretion was stimulated up
to 5.9  0.6-fold by TGF-1 alone. (P
 0.78). The effects of the three cytokines were much
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Fig. 9. Relative activity of the E-cadherin (A) and FSP-1 (B) promoter
after stimulation with 1 ng/mL EGF, FGF-2, TGF-1 alone or in combi-
nation. NP1 tubular epithelial cells were stably transfected and incu-
bated with the relative cytokine for 48 h. Combinations of TGF-1 
EGF (for FSP1) and TGF-1  FGF-2 (for E-cadherin) had the most
robust effects on promoter activity. Values are given in percent of
unstimulated controls.
more robust in NP1 cells (Fig. 12). MMP-2 was induced
up to 5.53  0.5-fold by FGF-2TGF-1, MMP-9 up to
5.5  0.24-fold by EGFTGF-1 (P 	 0.001 for both).
TGF-1 caused a 4.33  0.51-fold increase in MMP-2
and a 3.1  0.34-fold increase in MMP-9 (P 	 0.001 for
Fig. 10. ELISAs for collagen types I (A), IV (B) and fibronectin (C)both). Conversely, EGF and FGF-2 significantly induced
in NP1 cells after stimulation for 72 hours. TGF-1 had the most robustMMP-9 but not MMP-2 (P 
 0.08 for EGF and P 
 influence on collagen type I secretion. Coadministration of FGF-2 re-
0.12 for FGF-2). Thus, again, FGF-2 had comparable duced this effect, and coadministration of EGF abolished it. Conversely,
the effects of TGF-1 on collagen type IV and on fibronectin secretioneffects to EGF, and potentiated TGF-1–induced ef-
were potentiated by EGF and FGF-2 whereas the two cytokines had no
fects. However, it should be noted that activation of noticeable effect by themselves. Symbols are: () MCT; ( ) NPI cells.
*P 	 0.05; ** P 	 0.01.MMPs is tightly regulated for obvious reasons and that
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Fig. 11. Immunoblot analyses for fibronectin in
NP1-tubular epithelial cells after stimulation with
EGF (A), FGF-2 (B), TGF-1 (C ), TGF-1 
EGF (D), and TGF-1 FGF-2 (E ). Fibronectin
standard (FN) is depicted in addition in E. Ex-
pression of fibronectin was increased by all three
cytokines considerably starting 24 h after stimula-
tion. The dose dependency of FGF-2 on fibronec-
tin expression is depicted in part F (simulation
for 72 h).
MMPs are secreted as latent form. We did not observe any cells [2], whereas Fan and coworkers described tubular
transdifferentiation induced by high doses of TGF-1additional bands that could indicate activated MMP-2
[30]. Recently, Yang and Liu used a similar approach asor MMP-9. Thus, activation is still required after secre-
we did to dissect the key events in TGF-1 induced EMTtion for these two enzymes to become active.
[31]. Of particular significance is their finding that these
in vitro findings can be recapitulated in vivo in the mouse
DISCUSSION model of unilateral ureteral obstruction.
The differentiation state of a cell is not static but dis- Epithelial growth factor can induce phenotypic changes
plays plasticity depending on its environment [13]. The converting epithelium to a mesenchymal phenotype [32]
extracellular matrix plays a particularly important role and may promote cell motility in mammary epithelial
in modulating this plasticity. Definitive epithelia from cells [33]. Expression of EGF and EGFR is increased in a
organs such as the thyroid gland or lens epithelium con- rat model of interstitial fibrosis and in human chronic re-
vert into a mesenchymal phenotype when cultured in nal diseases [34, 35]. Exciting studies by Terzi et al demon-
three-dimensional collagen gels [25]. Moreover, vascular strated a beneficial effect of EGF receptor mutations
smooth muscle cells alter from a contractile to a synthetic indicating a possible role of the EGF system in fibrogen-
phenotype at contact with fibronectin or collagen type esis [36], although this was could not be confirmed for all
I [26]. In addition to extracellular matrix, cytokines also models [37]. FGF-2, on the other hand, has an important
are integral facilitators of plasticity called cellular trans- function for the development of mesenchymal cells [38].
differentiation. TGF- is one of the most important cyto- It induces transdifferentiation of retinal epithelial cells
kines in EMT [27]. Most forms of embryonic EMT rely into neuronal retinal cells [39] and has been implicated
on the presence of TGF-, for example, transdifferentia- in regulating the cell phenotype of primary epithelium
tion of epithelial cells of the mammary gland [28] and [40]. Increased expression of FGF-2 has been described
prostate [29]. The combination of TGF- and EGF has in animal models of lung and liver fibrosis. Injections of
been identified as an efficient cytokine combination in FGF-2 into rats for up to 13 weeks resulted in focal seg-
mental glomerulosclerosis and increase of the peritubu-driving conversion of tubular epithelial to mesenchymal
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epithelial cell line Madin-Darby canine kidney (MDCK)
disaggregates and converts into fibroblast-like cells af-
ter treatment with neutralizing antibodies to E-cadherin
[44]. Loss of epithelial adhesion properties represents an
early event in the process of EMT [31] that is sequentially
followed by the loss of cytoskeletal epithelial and the ac-
quisition of mesenchymal protein expression before com-
pletion [14]. The modest down-regulatory effects of all
three cytokines were complemented by robust inhibitory
effects on the E-cadherin promoter. We chose an up-
stream fragment (positions 214 to 92) since it dis-
played the highest epithelial specificity in kidney cells.
This region is known to contain a GC-rich region that
generates basic epithelial promoter activity and a palin-
dromic sequence that potentiates that activity [44]. The
effects of all three cytokines were more robust on the
promoter than on the protein possibly due to long pro-
tein half-life [24]. However, even the promoter activity
for E-cadherin was not completely abolished, indicating
that the process of EMT cannot be induced to comple-
tion by one cytokine alone but requires an interplay of
various growth factors. Furthermore, we chose to analyze
far lower concentrations than the ones applied by Fan
et al [30].
Conversely to epithelial cell markers, expressions of
FSP1 and SMA were up-regulated by FGF-2. The up-
regulatory effect on FSP1 expression was paralleled by
stimulation of the FSP1 promoter. We studied an 1800 bp
fragment with proven fibroblast specificity containing a
Fig. 12. Gelatin zymography of MCT and NP1 cells after stimulation fibroblast specific transcription site [11, 21]. The effects
with EGF, FGF-2, TGF-1 or combinations including TGF-1. MMP-2
on FSP1 promoter activity were robust, but again a com-and MMP-9 were visualized by negative staining with Coomassie bril-
liant blue dye solution. (A) A representative zymogram. (B) Proteolytic bination of cytokines was more efficient than each cyto-
bands were scanned densitometrically and percentages of control values kine alone. We did not study the exact mechanisms of
were calculated from 3 independent experiments. Symbols are: ()
cytokine stimulation (or inhibition in the case of theMCT; () NPI; *P 	 0.05; ** P 	 0.01.
E-cadherin promoter) since this was beyond the purpose
of this study, but further studies using the stably trans-
fected cell lines will permit us these analyses.
lar interstitium [41]. Furthermore, interstitial overexpres- Interestingly, the three cytokines did not act synergisti-
sion of the cytokine has been described in a mouse model cally on the expression of all markers. FGF-2, for exam-
of chronic HIV-related nephropathy associated with pro- ple, induced de novo expression of OB-cadherin in NP-1
gressive fibrosis [42]. We have recently identified up-reg- cells, unlike TGF-1. OB-cadherin belongs to the family
ulated FGF-2 protein and its mRNA in interstitial and of atypical cadherins [45]. The structural features of this
tubular epithelial cells in human kidneys with tubuloin- family resemble those of the classical cadherins with the
terstitial scarring [17]. In that study, interstitial FGF-2 exception that the classical cadherins lack the cell adhe-
staining correlated with tubular and interstitial prolifera- sion recognition sequence His-Ala-Val in the first extra-
tive activity pointing to a pro-mitogenic effect in vivo. cellular domain [46]. The biological function of OB-cad-
This study demonstrates that FGF-2 may induce EMT herin has not been determined in its entirety, however,
in tubular epithelial cells in vitro. Similar to TGF-1, it may play a role in calcium-dependent cell adhesion of
FGF-2 reduced expression of cytokeratin and E-cadherin mesenchymal cells, for example in osteoblasts where it
and induced expression of vimentin, FSP1 and SMA. was first described. Osteoblasts may be derived from
Though TGF-1 by itself had the most profound effects bone marrow fibroblasts and it is of particular interest in
on cytokeratin and E-cadherin expression, its effects were that regard that FGF-2 may induce such a differentiation
substantially potentiated by FGF-2. E-cadherin represents step [47]. The description of OB-cadherin in tubular
the principal epithelial cell-cell adhesion molecule and is epithelial cells and its induction is novel and warrants
further analysis.responsible for the integrity of epithelial layers [43]. The
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Loss of integrity of the basement membrane is an im- on epithelial and mesenchymal marker proteins seem to
be regulated on the promoter level. One important con-portant part of EMT. When MDCK cells are forced from
tribution of FGF-2 to EMT is the stimulation of micro-the surface of the basement membrane they grow on,
environmental proteases. Finally, the effects of FGF-2they develop mesenchymal characteristics [48]. Ng and
are potentiated by additional incubation with TGF-1.coworkers localized tubular epithelial cells undergoing
EMT as indicated by expression of SMA in the vicinity
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